A 66-year-old man with chronic HFrEF (EF 25%), NYHA II, K+ 4.8 mEq/L, eGFR 48. He takes ACE inhibitor, beta-blocker, and SGLT2 inhibitor. Next agent w...

Question

A 66-year-old man with chronic HFrEF (EF 25%), NYHA II, K+ 4.8 mEq/L, eGFR 48. He takes ACE inhibitor, beta-blocker, and SGLT2 inhibitor. Next agent with mortality benefit?

Accepted Answer

Add spironolactone 25 mg daily

Answer

Add verapamil

Answer

Add digoxin for survival benefit

Answer

Add ranolazine

Answer

Stop ACE inhibitor and start hydralazine alone

us-abim MCQ (SBA): Heart Failure (MRA Use)

A 66-year-old man with chronic HFrEF (EF 25%), NYHA II, K+ 4.8 mEq/L, eGFR 48. He takes ACE inhibitor, beta-blocker, and SGLT2 inhibitor. Next agent with mortality benefit?